 BRISBANE, Calif., May 05, 2022 GLOBE NEWSWIRE -- Vera Therapeutics, Inc. Nasdaq: VERA, a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Companys management team will present and participate in one-on-one meetings at the following conferences in May, as detailed below: 